Average sugar to HbA1c conversion is a key concept for anyone managing or monitoring diabetes. HbA1c — or glycated haemoglobin — reflects your average blood glucose levels over the preceding two to three months, making it far more informative than a single finger-prick reading. Understanding how your daily blood sugar figures translate into an HbA1c result can help you interpret test results, set realistic targets, and have more informed conversations with your GP or diabetes team. This article explains the science behind the conversion, the NHS and NICE diagnostic thresholds, and the factors that can affect your result.

What Is HbA1c and How Does It Relate to Average Blood Sugar?

HbA1c measures the percentage of haemoglobin with glucose attached, providing a reliable average of blood glucose levels over the preceding two to three months. It is the primary diagnostic and monitoring test for diabetes in adults, as recommended by NICE and the NHS.

HbA1c — formally known as glycated haemoglobin — is a blood test that reflects your average blood glucose (sugar) levels over the preceding two to three months. It works by measuring the proportion of haemoglobin (the oxygen-carrying protein in red blood cells) that has glucose attached to it. Because red blood cells have a lifespan of approximately 90 to 120 days, the HbA1c result provides a reliable long-term snapshot of blood sugar control, rather than a single point-in-time reading. In practice, the test is most heavily weighted towards the preceding eight to twelve weeks.

When blood glucose levels are consistently elevated, more glucose binds to haemoglobin, resulting in a higher HbA1c reading in millimoles per mole (mmol/mol) — the unit used as standard in the UK. Conversely, well-controlled blood sugar produces a lower HbA1c. This makes it a cornerstone test in the diagnosis and ongoing management of diabetes in adults.

HbA1c is used principally to diagnose type 2 diabetes in adults and to monitor glycaemic control in both type 1 and type 2 diabetes. However, it must not be used to diagnose diabetes in the following situations: suspected type 1 diabetes, children and young people, pregnancy (including gestational diabetes), acute illness or acute-onset hyperglycaemia, or where significant anaemia, haemoglobin variants, or other conditions affecting red cell turnover are present. In these circumstances, plasma glucose measurements are used instead.

Unlike a fasting glucose test or a finger-prick reading, HbA1c is generally not affected by short-term fluctuations such as a recent meal or a stressful day. However, it can be affected by recent blood transfusion, acute haemolysis, high-dose corticosteroids, or rapid changes in glycaemic control, all of which may produce a result that does not accurately reflect longer-term average glucose. The NHS routinely uses HbA1c as the primary monitoring tool for people living with diabetes, in line with NICE guidelines (NG17, NG28) and the WHO 2011 diagnostic criteria.

How to Convert Average Blood Glucose to an HbA1c Reading

The ADAG-derived eAG formula converts HbA1c to average glucose in mmol/L; for example, an HbA1c of 48 mmol/mol (6.5%) equates to approximately 7.8 mmol/L. These are estimates and eAG is not routinely reported on UK laboratory results.

Understanding the relationship between average blood glucose and HbA1c can help patients and clinicians interpret results more meaningfully. The concept of estimated average glucose (eAG) was developed to bridge this gap, translating HbA1c values into the familiar mmol/L units used on home glucose monitors.

The widely used conversion formula, derived from the ADAG (A1c-Derived Average Glucose) study (Nathan et al., NEJM 2008), is:

• eAG (mmol/L) = (1.5944 × HbA1c in %) − 2.5944

As a practical reference, the approximate eAG values for common HbA1c readings are:

• HbA1c of 48 mmol/mol (6.5%) ≈ average glucose of ~7.8 mmol/L

• HbA1c of 53 mmol/mol (7.0%) ≈ average glucose of ~8.6 mmol/L

• HbA1c of 64 mmol/mol (8.0%) ≈ average glucose of ~10.2 mmol/L

• HbA1c of 75 mmol/mol (9.0%) ≈ average glucose of ~11.8 mmol/L

These figures are estimates, not exact equivalences, and eAG is not routinely reported on UK laboratory results. Reputable online calculators, such as those provided by Diabetes UK, can assist with conversions, but results should always be discussed with your diabetes team.

Home glucose monitoring captures readings at specific moments — before meals, after meals, or during hypoglycaemic episodes — whereas HbA1c reflects a continuous weighted average. Patients who experience frequent hypoglycaemia may have a deceptively low HbA1c despite significant glucose variability. For this reason, clinicians consider both HbA1c and self-monitored glucose data together when reviewing diabetes management.

It is also important to note that the eAG–HbA1c relationship may be less reliable in certain groups, including people with chronic kidney disease (particularly those on dialysis), haemoglobin variants, pregnancy, or other conditions that alter red cell lifespan. In these situations, continuous glucose monitoring (CGM) or alternative markers such as fructosamine or glycated albumin may be more informative, as recommended by NICE (NG17, NG28).

Factors That Can Affect Your HbA1c Result

Haemolytic anaemia, iron deficiency, recent blood transfusion, pregnancy, and haemoglobin variants can all falsely lower or raise HbA1c, making the result unreliable. In these situations, alternative markers such as fructosamine or continuous glucose monitoring should be considered.

While HbA1c is a robust and reliable test, several physiological and medical factors can influence the result, sometimes producing readings that do not accurately reflect true average blood glucose. Being aware of these variables is important for both patients and healthcare professionals when interpreting results.

Conditions that may falsely lower HbA1c:

• Haemolytic anaemia — increased red blood cell turnover means cells are replaced more quickly, reducing the time available for glucose to bind to haemoglobin

• Iron deficiency anaemia (when treated with iron supplementation) — production of new red blood cells can lower HbA1c

• Recent blood transfusion — introduces donor red blood cells that have not been exposed to the patient's glucose levels

• Pregnancy — particularly in the second and third trimesters, increased red cell turnover makes HbA1c unreliable; HbA1c is not recommended for diagnosing gestational diabetes and has significant limitations for monitoring during pregnancy (NICE NG3)

• Certain medications, including hydroxycarbamide (also known as hydroxyurea), dapsone, and erythropoietin

Conditions that may falsely raise HbA1c:

• Iron deficiency anaemia (untreated) — reduced red cell production prolongs cell lifespan, allowing more glucose binding

• Vitamin B12 or folate deficiency

• Splenectomy

Haemoglobin variants (for example, HbS in sickle cell trait, HbC, HbE) can raise or lower HbA1c depending on the laboratory assay method used, and may interfere with the accuracy of the result. If a haemoglobin variant is known or suspected, your local laboratory should be consulted about the most appropriate assay or alternative test (such as fructosamine or glycated albumin).

Chronic kidney disease (CKD) can make HbA1c unreliable. In moderate-to-severe CKD and particularly in end-stage renal disease, shortened red cell lifespan often leads to a falsely low HbA1c; some assays may also be affected by uraemia. In these patients, alternative markers of glycaemic control or CGM should be considered, in line with NICE guidance.

Patients should always inform their GP or diabetes team of any relevant medical conditions or medications before undergoing HbA1c testing, to ensure results are interpreted in the correct clinical context. Where HbA1c is unreliable, the diabetes team will advise on suitable alternatives.

What HbA1c Levels Mean According to NHS and NICE Guidelines

An HbA1c below 42 mmol/mol is normal, 42–47 mmol/mol indicates non-diabetic hyperglycaemia, and 48 mmol/mol or above is diagnostic of diabetes in asymptomatic adults. NICE recommends a treatment target of 48 mmol/mol for most adults with type 2 diabetes managed by lifestyle or a single non-hypoglycaemic drug.

In the UK, HbA1c results are reported in mmol/mol and interpreted according to thresholds established by NICE and adopted across NHS services. Understanding what these numbers mean can help patients take an active role in their health.

Diagnostic thresholds (NICE NG28; WHO 2011):

• Below 42 mmol/mol — Normal range; diabetes is unlikely

• 42–47 mmol/mol — Indicates non-diabetic hyperglycaemia (NDH), sometimes referred to as being at high risk of diabetes; this is the UK-preferred term rather than 'prediabetes'

• 48 mmol/mol or above — Diagnostic of diabetes (in asymptomatic adults, a second confirmatory test is required; a single result is sufficient if symptoms of diabetes are present)

HbA1c must not be used to diagnose diabetes in suspected type 1 diabetes, children, pregnancy, acute illness, or where haemoglobin variants or significant anaemia are present — plasma glucose testing should be used in these situations.

If your result falls in the NDH range (42–47 mmol/mol), your GP may refer you to the NHS Diabetes Prevention Programme, which offers structured lifestyle support to reduce your risk of developing type 2 diabetes.

Treatment targets for people with diabetes (NICE NG28, NG17):

• NICE recommends an HbA1c target of 48 mmol/mol (6.5%) for most adults with type 2 diabetes managed by lifestyle changes or a single non-hypoglycaemic drug

• A target of 53 mmol/mol (7.0%) is recommended for those on medications that carry a risk of hypoglycaemia, such as sulphonylureas or insulin

• For type 1 diabetes, NICE (NG17) recommends aiming for 48 mmol/mol (6.5%) if achievable without problematic hypoglycaemia; for most adults with type 1 diabetes, NICE also recommends CGM and encourages consideration of time-in-range metrics alongside HbA1c

Targets should always be individualised. For older adults, those with frailty, or individuals with a history of severe hypoglycaemia, less stringent targets may be appropriate to avoid harm. Tighter control may be advised in younger patients or those planning pregnancy.

When to seek medical advice:

• If your HbA1c is rising despite following your management plan, contact your GP or diabetes team

• If you are experiencing frequent hypoglycaemic episodes

• If your result is in the NDH range and you wish to discuss lifestyle interventions

• Seek same-day urgent medical attention if you or someone else develops symptoms that may suggest new-onset type 1 diabetes or diabetic ketoacidosis (DKA), including excessive thirst, frequent urination, unexplained weight loss, vomiting, abdominal pain, confusion, or rapid or laboured breathing. Do not wait for an HbA1c result in this situation — call 999 or go to your nearest emergency department

Regular HbA1c monitoring — typically every three to six months for people with diabetes, or annually for those at risk — remains one of the most effective tools for preventing long-term complications such as cardiovascular disease, neuropathy, and retinopathy.

Frequently Asked Questions